机构:[1]Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China临床科室心脏内科中心首都医科大学附属安贞医院[2]Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China医技科室医学影像科首都医科大学附属安贞医院
Objective This study was performed to assess the prevalence of nonalcoholic fatty liver (NAFL) in patients with symptomatic congestive heart failure (CHF) and compare the clinical features with those of patients without NAFL. Methods In total, 102 patients with CHF were divided into NAFL and non-NAFL groups according to their hepatic ultrasonography findings. All patients underwent transthoracic echocardiography and cardiac magnetic resonance examination. Follow-up was performed for major cardiovascular events (MACE) and readmission due to heart failure at 1, 3, 6, and 12 months after the index hospitalization. Results NAFL was detected in 37 of 102 patients (36.27%). Compared with the non-NAFL group, patients with NAFL were younger, had a higher body mass index and left ventricular (LV) mass index, and had more severe fibrosis. MACE and readmission occurred in 15 patients in the NAFL group and 29 patients in the non-NAFL group, without a significant difference. Linear regression analysis revealed that after adjusting for confounders, NAFL was independently associated with the LV fibrosis size and the ratio of the LV fibrosis size to the LV mass index. Conclusions NAFL is present in more than one-third of patients with CHF and is associated with the severity of LV fibrosis.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China [NSFC-81370290, NSFC-81770322, NSFC-81771787]; Beijing Natural Science FoundationBeijing Natural Science Foundation [7161003]; Capital Health Research and Development of Special [2016-2-2062, 2016-4-2063]
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类|4 区医学
小类|4 区医学:研究与实验4 区药学
最新[2023]版:
大类|4 区医学
小类|4 区医学:研究与实验4 区药学
JCR分区:
出版当年[2016]版:
Q4MEDICINE, RESEARCH & EXPERIMENTALQ4PHARMACOLOGY & PHARMACY
最新[2023]版:
Q4MEDICINE, RESEARCH & EXPERIMENTALQ4PHARMACOLOGY & PHARMACY
第一作者机构:[1]Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
通讯作者:
通讯机构:[1]Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China[*1]Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Anzhen Road No. 2, Chaoyang District, Beijing 100029, PR China.
推荐引用方式(GB/T 7714):
Zhang Zichuan,Wang Peize,Guo Fei,et al.Chronic heart failure in patients with nonalcoholic fatty liver disease: prevalence, clinical features, and relevance[J].JOURNAL OF INTERNATIONAL MEDICAL RESEARCH.2018,46(9):3959-3969.doi:10.1177/0300060518782780.
APA:
Zhang, Zichuan,Wang, Peize,Guo, Fei,Liu, Xinmin,Luo, Taiyang...&Bai, Rong.(2018).Chronic heart failure in patients with nonalcoholic fatty liver disease: prevalence, clinical features, and relevance.JOURNAL OF INTERNATIONAL MEDICAL RESEARCH,46,(9)
MLA:
Zhang, Zichuan,et al."Chronic heart failure in patients with nonalcoholic fatty liver disease: prevalence, clinical features, and relevance".JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 46..9(2018):3959-3969